Strength
25 mg/1
Manufacturer
AvPAKNDC
50268039850
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYZINE PAMOATEApproval Type
Generic (ANDA)
FDA Application
ANDA040156On Market Since
4/14/2021
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE PAM 25 MG CAP has been published 255 times since Aug 11, 2021, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0642 per EA |
|---|---|
| All-time high | $0.0778 (Dec 13, 2023) |
| All-time low | $0.0541 (Nov 20, 2024) |
| 52-week high | $0.0655 |
| 52-week low | $0.0630 |
| Median price | $0.0674 |
| Average price | $0.0680 |
| Largest weekly change | -15.9% (Nov 20, 2024) |
| Weeks tracked | 255 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYZINE PAM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 25 MG CAP, manufactured by AvPAK, is $0.0642 per EA (NDC 50268039850), effective Jun 24, 2026.
How has the price of HYDROXYZINE PAM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE PAM 25 MG CAP has declined 13.2%. It has been tracked across 255 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 25 MG CAP?
Since Aug 11, 2021, the NADAC for HYDROXYZINE PAM 25 MG CAP has ranged from a low of $0.0541 (Nov 20, 2024) to a high of $0.0778 (Dec 13, 2023), with a median of $0.0674 per EA.
Are there cheaper alternatives to HYDROXYZINE PAM 25 MG CAP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROXYZINE PAM 25 MG CAP, but none are currently priced below it.
Who manufactures HYDROXYZINE PAM 25 MG CAP?
HYDROXYZINE PAM 25 MG CAP (NDC 50268039850) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification